Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

December 4, 2008 | Customer News

Sample preparation and splitting on one laboratory platform


Tecan, a global leader in automated robotic systems, has developed Freedom EVOlution™ 2.1, its latest version of software for Freedom EVO® Clinical, Tecan’s 98/79/EC-IVD compliant, open and configurable liquid handling platform for a broad range of in vitro diagnostic applications. The software allows laboratories to integrate several applications on one instrument, and the new version offers additional application areas – sample splitting and archiving – in addition to all the existing sample preparation functions.


The new software makes it possible to automate the splitting of source tubes into multiple destination tubes, and the archiving of source tubes into archive plates, without the need for a LIS/LIMS connection. Sample traceability is maintained by barcodes on all source and destination tubes, and the workflows are standardized, making the Freedom EVO Clinical platform ideal for all laboratories handling clinical samples for analysis or archiving. Freedom EVOlution 2.1 is available as standard on new instruments, and as an upgrade option for existing instruments. To find out more on Tecan’s Freedom EVOlution, visit www.tecan.com/evolution.


About Tecan

Tecan (www.tecan.com) is a leading global supplier of laboratory instruments and solutions for the biopharma, forensic and diagnostic industries. The company specializes in the development, production and distribution of automation solutions for life science laboratories. Through its REMP subsidiary (www.remp.com), Tecan is the premier supplier of automated laboratory storage and logistics systems. Tecan's clients include pharmaceutical and biotech companies, university research departments, diagnostic laboratories and companies as well as forensics laboratories. Founded in Switzerland in 1980, the company has production, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2007, Tecan achieved sales of CHF 414.4 million (USD 345.3 million; EUR 252.7 million). Registered shares of the Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Valor: 1210019).

For more information about Tecan, please contact:

Tecan Group Ltd.
Cornelia Kegele
Seestrasse 103
CH-8708 Männedorf

T +41 44 922 81 11
F +41 44 922 81 12